Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Julie Mizraji has found community while living with metastatic breast cancer.
A new randomized study sought to clarify results from previous studies that suggested there would be a benefit from such local treatment.
Here’s a list of the approved drugs to treat breast cancer. Click on any of the medications for more info on dosing, side effects and...
The antibody-drug conjugate is the second drug approved for metastatic breast cancer in the course of a week.
Targeted therapy tucatinib improves survival in people with HER2-positive breast cancer that has spread to the brain.
“A customized blood biopsy test has the sensitivity needed to predict which patients are at risk of cancer recurrence.”
Former Air Force senior master sergeant Sheila McGlown, 53, has metastatic breast cancer. She lives with her husband near St. Louis.
Tucatinib fights breast cancer that spreads to the brain
The efficacy of Nerlynx with capecitabine was investigated in a randomized, multicenter, open-label clinical trial in 621 people.
In both clinical trials, women whose cancers had spread to the brain were eligible to participate.
60% of women treated with the antibody-drug conjugate experienced complete or partial tumor shrinkage.
Findings in mice point to new approach that may help make some metastatic breast cancers susceptible to immunotherapy
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.